Employee Benefit Plans (Tables)

6 Months Ended

Dec. 31, 2018

Share Based Compensation [Abstract]

Shares Reserved for Issuance

The Company had reserved for issuance for the periods noted (in thousands):

	December 31, 2018		June 30, 2018
2013 Equity Incentive Plan shares available for grant		7,558		9,957
Employee stock options and awards outstanding		11,577		12,060
2014 Employee Stock Purchase Plan		4,084		5,365
Total shares reserved for issuance		23,219		27,382

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):

	Three Months Ended				Six Months Ended
	December 31, 2018		December 31, 2017		December 31, 2018		December 31, 2017
Cost of product revenue	$	217	$	134	$	395	$	226
Cost of service revenue		677		296		1,022		429
Research and development		2,797		1,829		5,139		2,880
Sales and marketing		2,983		2,699		5,342		4,342
General and administrative		2,026		2,067		3,627		3,951
Total share-based compensation expense	$	8,700	$	7,025	$	15,525	$	11,828

Summary of Stock Award Activity

The following table summarizes stock award activity for the six months ended December 31, 2018 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Market Value
Non-vested stock awards outstanding at June 30, 2018		7,764		$	8.60	$	61,804
Granted		4,042			6.40
Released		(2,271	)		7.75
Cancelled		(738	)		8.66
Non-vested stock awards outstanding at December 31, 2018		8,797		$	7.80	$	53,661

Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended December 31, 2018 (in thousands, except per share and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2018		2,193		$	3.88		2.90	$	8,996
Granted		852			6.40
Exercised		(178	)		3.56
Cancelled		(87	)		6.01
Options outstanding at December 31, 2018		2,780		$	4.60		3.70	$	4,414
Vested and expected to vest at December 31, 2018		2,780		$	4.60		3.70	$	4,414
Exercisable at December 31, 2018		1,962		$	3.94		2.53	$	4,234

Schedule of Fair Value Assumptions for Stock Options and Employee Stock Purchase Plan Awards

The following assumptions were used to calculate the fair value of shares granted under the ESPP during the following periods:

	Employee Stock Purchase Plan
	Six Months Ended
	December 31, 2018			December 31, 2017
Expected life	0.5 years			0.5 years
Risk-free interest rate		2.20	%		1.15	%
Volatility		63	%		42	%
Dividend yield		—	%		—	%